Benchmark against your competition
Understand how AI crawlers access your site
See where AI gets info about you
Track the queries mentioning your brand
Own your AI narrative
Add GEO to your service offerings
Get recommended in shopping queries
Monitor AI mentions at scale
Agendia
What AI says about Agendia
Agendia provides advanced genomic testing solutions to guide early breast cancer treatment. Their flagship products, MammaPrint® and BluePrint®, deliver results in just 6 days, helping to personalize treatment decisions based on tumor biology and recurrence risk.
Is this your brand?
Claim this profile to keep your information accurate and add what's missing.
Not in this profile yet:
Products & Services
MammaPrint
A genomic test that assesses the risk of breast cancer recurrence.
BluePrint
A molecular subtyping test that determines the underlying genomics driving tumor growth.
Common Questions
What is MammaPrint?
MammaPrint is a genomic test that evaluates the likelihood of breast cancer recurrence.
How quickly can I get results?
Agendia provides results in just 6 days for most cases.
What does BluePrint do?
BluePrint is a molecular subtyping test that helps understand the genomics behind tumor growth.
Who can benefit from Agendia's tests?
Patients with early-stage breast cancer can benefit from personalized treatment decisions based on genomic testing.
Where is Agendia located?
Agendia has locations in Irvine, CA, USA, and Amsterdam, The Netherlands.